Exact Imaging
Exact Imaging has an experienced management team that has together and individually successfully launched multiple companies and products into global markets, developed global teams and commercial infrastructures, and achieved multiple liquidity events including IPOs (Visible Genetics) and acquisitions (Biomedical Instrumentation Inc., DICOMIT, Quinton Electrophysiology, VisualSonics, VisEn Medical, Visible Genetics). Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
The ExactVu micro-ultrasound platform provides the most practical solution as a new tool for urologists to perform targeted biopsies within a standard urological workflow.
Exact Imaging’s ExactVu™ micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and being an extension of the current urological workflow. Using the Exact Imaging platform, urologists are able to visualize areas of interest in the prostate and specifically target biopsies at those areas. For the minority of cases where MRI might assist (i.e., prior negative biopsies), FusionVu™ is the micro-US/MRI fusion application operating on the ExactVu micro-ultrasound platform - - and guided by the system's 70 micron real-time resolution.
The ExactVu micro-ultrasound system, including FusionVu, has received regulatory approval in the European Union (CE Mark), the United States (FDA 510(k)) and Canada (Health Canada medical device license).